These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15286736)

  • 1. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
    Shi Y; Burn P
    Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fat-normalizing nutrition. Therewith your patients escape from the yo-yo effect].
    MMW Fortschr Med; 2003 Mar; 145(13):58. PubMed ID: 15101543
    [No Abstract]   [Full Text] [Related]  

  • 3. Obesity: can a new drug help?
    Harv Mens Health Watch; 1999 Oct; 4(3):6-8. PubMed ID: 10529295
    [No Abstract]   [Full Text] [Related]  

  • 4. Is blockade of pancreatic lipase the answer?
    Halsted CH
    Am J Clin Nutr; 1999 Jun; 69(6):1059-60. PubMed ID: 10357720
    [No Abstract]   [Full Text] [Related]  

  • 5. Orlistat for obesity.
    Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767
    [No Abstract]   [Full Text] [Related]  

  • 6. Cetilistat, a new lipase inhibitor for the treatment of obesity.
    Padwal R
    Curr Opin Investig Drugs; 2008 Apr; 9(4):414-21. PubMed ID: 18393108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orlistat half the dose without a prescription: new status. In excess body weight: often uncomfortable and don't expect miracles. Frequent gastrointestinal disturbances for a weight loss of a few kilos. Better to encourage dietary measures, exercise and individualised support.
    Prescrire Int; 2009 Jun; 18(101):101. PubMed ID: 19637413
    [No Abstract]   [Full Text] [Related]  

  • 8. I am about 15 lbs. overweight. Do you recommend the new over-the-counter diet pill Alli?
    Johns Hopkins Med Lett Health After 50; 2007 Jun; 19(4):8. PubMed ID: 17647299
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural inhibitors of pancreatic lipase as new players in obesity treatment.
    de la Garza AL; Milagro FI; Boque N; Campión J; Martínez JA
    Planta Med; 2011 May; 77(8):773-85. PubMed ID: 21412692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orlistat: medically induced malabsorption of the fat in the treatment of severe obesity].
    Hendel HW; Andersen T
    Ugeskr Laeger; 1999 Nov; 161(44):6068-72. PubMed ID: 10778347
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care?
    Leiser JP; Gunning K
    J Fam Pract; 2000 Jun; 49(6):572-3. PubMed ID: 10923560
    [No Abstract]   [Full Text] [Related]  

  • 12. Modern, new pharmacotherapy for obesity. A gastrointestinal approach.
    Van Gaal L; Mertens I; Ballaux D; Verkade HJ
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1049-72. PubMed ID: 15561638
    [No Abstract]   [Full Text] [Related]  

  • 13. Blockade of pancreatic lipase.
    Blackburn GL
    Am J Clin Nutr; 2000 Mar; 71(3):845-6. PubMed ID: 10702184
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does orlistat really offer help for the treatment of obesity?].
    Orozco P
    Aten Primaria; 1999 Nov; 24(8):445-6. PubMed ID: 10630025
    [No Abstract]   [Full Text] [Related]  

  • 15. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
    Svendsen M; Helgeland M; Tonstad S
    J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current drug formulations in obesity therapy].
    Ellrott T
    Dtsch Med Wochenschr; 2000 Mar; 125(9):256-61. PubMed ID: 10742818
    [No Abstract]   [Full Text] [Related]  

  • 17. More about orlistat.
    Lucas KH; Kaplan-Machlis B
    Pharmacotherapy; 2000 Jul; 20(7):872-3. PubMed ID: 10907983
    [No Abstract]   [Full Text] [Related]  

  • 18. The obesity pipeline: current strategies in the development of anti-obesity drugs.
    Cooke D; Bloom S
    Nat Rev Drug Discov; 2006 Nov; 5(11):919-31. PubMed ID: 17080028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity drug endorsed by NICE.
    Wise J
    BMJ; 2001 Mar; 322(7287):637. PubMed ID: 11250844
    [No Abstract]   [Full Text] [Related]  

  • 20. [Orlistat and articles accepted for publication in Medicina Clínica].
    Zambrana García JL; Cruz Caparrós G; Salas Coronas J; Díez García F
    Med Clin (Barc); 1999 Nov; 113(18):716. PubMed ID: 10650576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.